Company news
Guardant Health, Inc. news in 2022
Guardant Health, Inc.'s news releases, calls and decks from 2022, newest first.
Guardant Health to Participate in the 41st Annual J.P. Morgan Healthcare Conference
December 27, 2022
Guardant Health and Susan G. Komen® Partner to Develop Clinical Studies to Identify Early-Stage Breast Cancer Patients Who May Benefit From Additional Monitoring or Therapy
December 20, 2022
Guardant Health announces positive results from pivotal ECLIPSE study evaluating a blood test for the detection of colorectal cancer
December 14, 2022
Guardant Health Announces Collaboration With AstraZeneca to Develop Companion Diagnostic to Identify Patients With ESR1-mutated Metastatic Breast Cancer
December 7, 2022
Guardant Health to Showcase New Data at San Antonio Breast Cancer Symposium 2022 Demonstrating Utility of Its Blood Tests for Advanced-stage Breast Cancer Patients
November 30, 2022
Guardant Health Reports Third Quarter 2022 Financial Results
November 2, 2022
Guardant Health to Report Third Quarter 2022 Financial Results on November 3, 2022
October 9, 2022
Guardant Health Introduces GuardantINFINITY™ Smart Liquid Biopsy for Research Use to Help Bring New Cancer Therapies to Patients Sooner
September 8, 2022
Guardant Health to showcase new data at ESMO 2022 demonstrating utility of its portfolio of blood tests for advanced-stage cancer patients
September 5, 2022
Guardant Health Expands Strategic Collaboration With Merck KGaA, Darmstadt, Germany, to Help Accelerate Development of Precision Oncology Therapeutics
August 30, 2022
Guardant Health to Participate in the Morgan Stanley Global Healthcare Conference
August 28, 2022
Guardant Health Expands Use of Guardant Reveal™ Liquid Biopsy Test for Residual Disease Detection and Recurrence Monitoring to Include Early-Stage Breast and Lung Cancers
August 14, 2022
Guardant Health Receives FDA Approval for Guardant360® CDx as Companion Diagnostic for Daiichi Sankyo and AstraZeneca’s ENHERTU® for Treatment of NSCLC Patients With Activating HER2 Mutations
August 11, 2022
Guardant Health Announces New Data from its Portfolio of Blood Tests and GuardantINFORM™ Real-World Clinical-Genomic Platform at IASLC 2022 World Conference on Lung Cancer
August 4, 2022
Guardant Health Reports Second Quarter 2022 Financial Results
August 3, 2022
Guardant Health Receives Medicare Coverage for Guardant Reveal™ Test
August 1, 2022
Guardant Health to Report Second Quarter 2022 Financial Results on August 4, 2022
July 12, 2022
Steve E. Krognes Joins Guardant Health Board of Directors
July 6, 2022
Guardant Health and Adicon announce strategic partnership to offer comprehensive genomic profiling tests to accelerate development of new cancer therapies in China
July 5, 2022
Guardant Health Completes Purchase of Guardant Health AMEA Joint Venture
June 12, 2022
Guardant Health Presents New Data Showing Blood Test Accuracy in Detecting Colorectal Cancer in First-of-its Kind Prospective Study at Digestive Disease Week 2022
May 20, 2022
Guardant Health Reports First Quarter 2022 Financial Results
May 4, 2022
Guardant Health Announces Shield™ Blood Test Available in US to Detect Early Signs of Colorectal Cancer in Average-Risk Adults
May 1, 2022
Guardant Health to Report First Quarter Financial Results on May 5, 2022
April 12, 2022
Guardant Health Presents New Data Showing Blood Test Highly Accurate in Detecting Multiple Cancers at the American Association for Cancer Research Annual Meeting
April 10, 2022
Guardant Health Announces Partnership with Epic to Streamline Access to Company’s Broad Portfolio of Cancer Tests
April 3, 2022
Guardant Health Receives Regulatory Approval for Guardant360® CDx in Japan
March 13, 2022
Guardant Health Receives Medicare Coverage for Guardant360 TissueNext™ Test
March 7, 2022
Guardant Health Reports Fourth Quarter 2021 Financial Results and Provides 2022 Outlook
February 22, 2022
Guardant Health Enrolls First Patient in SHIELD LUNG Study to Evaluate Accuracy of Its Blood Test to Detect Lung Cancer in High-Risk Adults
January 17, 2022
Calls in 2022
Decks in 2022
- Technical Presentation (December 2022)
Technical · 10 slides · Dec 15, 2022
- Q3 2022 Earnings Presentation
Earnings · 17 slides · Nov 3, 2022
- Q2 2022 Earnings Presentation
Earnings · 17 slides · Aug 4, 2022
- William Blair 42nd Annual Growth Stock Conference 2022
Conference · 19 slides · Jun 7, 2022
- Technical Presentation (2022)
Technical · 11 slides · May 24, 2022
- Q1 2022 Earnings Presentation
Earnings · 18 slides · May 5, 2022
- Q4 2021 Earnings Presentation
Earnings · 20 slides · Feb 23, 2022